Sugi Predict

Sugi Predict / Compounds / SCHEMBL1604484

SCHEMBL1604484

SCHEMBL1604484

CCCCCCC(=O)C(C)C

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 4/20 0.64
▸ MEN1 O00255 1/20 0.59
▸ FAAH O00519 1/20 0.59
▸ MAPK1 P28482 1/20 0.59
▸ KMT2A Q03164 1/20 0.59
▸ CES1 P23141 3/20 0.56
▸ GPR84 Q9NQS5 2/20 0.54
▸ PPARG P37231 2/20 0.54
▸ PPARD Q03181 2/20 0.54
▸ PPARA Q07869 2/20 0.54
▸ ALDH1A1 P00352 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ SLC22A6 Q4U2R8 1/20 0.54
▸ SLC22A8 Q8TCC7 1/20 0.54
▸ TLR2 O60603 1/20 0.54
▸ HDAC11 Q96DB2 1/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5181793 1.00 CES2 (0.64) CES2MEN1FAAHMAPK1KMT2A
SCHEMBL8773299 1.00 CES2 (0.64) CES2MEN1FAAHMAPK1KMT2A
SCHEMBL19103607 1.00 CES2 (0.64) CES2MEN1FAAHMAPK1KMT2A
SCHEMBL14477972 1.00 CES2 (0.64) CES2MEN1FAAHMAPK1KMT2A
SCHEMBL23950236 1.00 CES2 (0.64) CES2MEN1FAAHMAPK1KMT2A
SCHEMBL21448801 1.00 CES2 (0.64) CES2MEN1FAAHMAPK1KMT2A
SCHEMBL23950131 1.00 CES2 (0.64) CES2MEN1FAAHMAPK1KMT2A
SCHEMBL23950441 1.00 CES2 (0.64) CES2MEN1FAAHMAPK1KMT2A
SCHEMBL23950237 1.00 CES2 (0.64) CES2MEN1FAAHMAPK1KMT2A
SCHEMBL827134 1.00 CES2 (0.64) CES2MEN1FAAHMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116669572-A Heat treated soy flour 皆食得公司 2023-08-29 — — CN claimed
CN-101494999-A Method for using organic compound GIVAUDAN SA (CH) 2009-07-29 — — CN claimed
EP-0622451-B1 Perfumed hypochlorite bleaching compositions PROCTER & GAMBLE (US) 1998-12-02 — — EP claimed
US-4240983-A HALOGENATION BAYER AKTIENGESELLSCHAFT (DE) 1980-12-23 — — US claimed
US-12222653-B2 Method for forming semiconductor structure TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2025-02-11 — — US disclosed
US-20250000088-A1 ANT CONTROL AGENT AND ANT CONTROL METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-01-02 — — US disclosed
EP-4424164-A1 ANT CONTROL AGENT AND ANT CONTROL METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-09-04 — — EP disclosed
US-11911412-B2 Derivatized chitosan polymers and methods of treating vascular disorders SYNEDGEN, INC. (US) 2024-02-27 — — US disclosed
US-11786547-B2 Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds SYNEDGEN, INC. (US) 2023-10-17 — — US disclosed
US-20230303512-A1 MODULATORS OF MYB-MEDIATED TRANSCRIPTION AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-09-28 — — US disclosed
CN-116669572-A Heat treated soy flour 皆食得公司 2023-08-29 — — CN disclosed
US-11718637-B2 Prodrugs of 4′-C-substituted-2-halo-2′- deoxyadenosine nucleosides and methods of making and using the same GILEAD SCIENCES, INC. (US) 2023-08-08 — — US disclosed
US-7504411-B2 2,3,6-Trisubstituted-4-pyrimidone derivatives MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-03-17 — — US disclosed
WO-2008084046-A1 PLASTICIZERS FOR POLYVINYL ACETALS AND POLYSULFIDES BASF SE (DE) 2008-07-17 — — WO disclosed
US-20070078146-A1 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma PHARMACIA CORPORATION 2007-04-05 — — US disclosed
US-4666529-A Method for reducing combustion chamber deposits from an internal combustion engine SHELL OIL COMPANY (US) 1987-05-19 — — US disclosed
US-4240983-A HALOGENATION BAYER AKTIENGESELLSCHAFT (DE) 1980-12-23 — — US disclosed
US-4043790-A 2-OR 4-SUBSTITUTED PYRIDINE METHANE OR PYRIDINE METHANOL, NONHERBICIDAL ELI LILLY AND COMPANY (US) 1977-08-23 — — US disclosed
US-3975373-A CYCLOPENTANONE HELVETICOSIDE JOHANN A. WULFING FABRIK PHARMAZEUTISCHER PRAPARATE (DT) 1976-08-17 — — US disclosed
US-3951946-A Cardioglycoside derivatives of the strophanthidin type, a process for their manufacture and medicinal preparations containing these compounds JOHANN A. WULFING FABRIK PHARMAZEUTISCHER PRAPARATE (DT) 1976-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303512-A1 MODULATORS OF MYB-MEDIATED TRANSCRIPTION AND USES THEREOF MYB, MYBBP1A, MYCBP CES2 3789/4885MEN1 3806/4885FAAH 4782/4885
US-20070078146-A1 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma MAPK1, MAPK3, MAPK4 CES2 4820/4885MEN1 3032/4885FAAH 1086/4885
US-11718637-B2 Prodrugs of 4′-C-substituted-2-halo-2′- deoxyadenosine nucleosides and methods of making and using the same DCTD, MTAP, ADA CES2 73/4885MEN1 4076/4885FAAH 2357/4885
US-11786547-B2 Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds CHIT1, ALG1, CSGALNACT1 CES2 1738/4885MEN1 3513/4885FAAH 816/4885
US-11911412-B2 Derivatized chitosan polymers and methods of treating vascular disorders CHIA, CHI3L1, CHI3L2 CES2 351/4885MEN1 3683/4885FAAH 2298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.